Cullinan Oncology Inc. (CGEM)
10.01
-1.03 (-9.33%)
At close: Jan 14, 2025, 3:59 PM
10.35
3.39%
Pre-market Jan 15, 2025, 05:15 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | 18.94M | n/a | n/a | n/a |
| Cost of Revenue | 310.00K | 93.00K | 53.00K | 62.00K | 70.00K | 43.00K |
| Gross Profit | -310.00K | -93.00K | 18.89M | -62.00K | -70.00K | -43.00K |
| Operating Income | -191.09M | 144.65M | -67.95M | -60.34M | -22.27M | -14.59M |
| Interest Income | 21.63M | 6.61M | 477.00K | 888.00K | 620.00K | 397.00K |
| Pretax Income | -169.22M | 151.32M | -67.48M | -59.46M | -21.65M | -14.19M |
| Net Income | -153.16M | 111.21M | -65.04M | -50.85M | -20.04M | -14.19M |
| Selling & General & Admin | 42.49M | 40.19M | 29.15M | 17.12M | 5.48M | 5.00M |
| Research & Development | 148.16M | 91.95M | 57.75M | 43.21M | 16.79M | 9.58M |
| Other Expenses | 440.00K | 57.00K | -8.00K | -11.00K | -4.00K | n/a |
| Operating Expenses | 191.09M | 132.14M | 86.90M | 60.34M | 22.27M | 14.59M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 191.09M | 132.14M | 86.90M | 60.34M | 22.27M | 14.59M |
| Income Tax | -14.12M | 42.12M | -2.44M | -8.61M | -1.62M | 397.00K |
| Shares Outstanding (Basic) | 41.51M | 45.16M | 44.29M | 43.52M | 43.52M | 11.45M |
| Shares Outstanding (Diluted) | 41.55M | 46.64M | 44.29M | 43.52M | 43.52M | 11.45M |
| EPS (Basic) | -3.69 | 2.46 | -1.47 | -1.17 | -0.46 | -1.24 |
| EPS (Diluted) | -3.69 | 2.38 | -1.47 | -1.17 | -0.46 | -1.24 |
| EBITDA | -190.34M | 151.41M | -67.90M | -60.27M | -22.20M | -14.54M |
| Depreciation & Amortization | 310.00K | 93.00K | 53.00K | 62.00K | 70.00K | 43.00K |